当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析

以岭药业

(002603)

  

流通市值:235.03亿  总市值:285.19亿
流通股本:13.77亿   总股本:16.71亿

以岭药业(002603)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润9.97亿元,每股收益0.60元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1069765.18万元,未分配利润577955.27万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1422030.91万元,负债352265.74万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入5,867,603,073.614,040,142,217.942,358,232,707.776,512,734,471.77
营业总成本4,704,006,732.643,245,278,851.391,946,902,188.17,147,123,381.22
其他经营收益
营业利润1,187,306,072.6821,536,367.61398,572,313.82-688,895,452.05
利润总额1,169,635,400.22803,653,759.54394,121,050.36-800,192,007.83
净利润996,674,335.9665,298,290.44324,155,914.76-734,183,532.26
每股收益
其他综合收益96,367.62-115,833.71-54,894.21-507,389.2
综合收益总额996,770,703.52665,182,456.73324,101,020.55-734,690,921.46
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,539,592,346.045,167,877,833.074,794,368,334.24,334,951,809.12
非流动资产:
非流动资产合计8,680,716,780.668,731,435,279.688,899,719,678.68,984,219,279.16
资产总计14,220,309,126.713,899,313,112.7513,694,088,012.813,319,171,088.28
流动负债:
流动负债合计3,000,577,881.412,526,367,038.152,661,153,079.612,606,688,892.16
非流动负债:
非流动负债合计522,079,488.86505,670,952.16506,741,246.93510,389,530.41
负债合计3,522,657,370.273,032,037,990.313,167,894,326.543,117,078,422.57
所有者权益(或股东权益):
归属于母公司股东权益合计10,703,839,026.9310,872,968,791.2210,549,386,134.3110,223,487,732.27
股东权益合计10,697,651,756.4310,867,275,122.4410,526,193,686.2610,202,092,665.71
负债和股东权益合计14,220,309,126.713,899,313,112.7513,694,088,012.813,319,171,088.28
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计6,391,353,472.814,302,887,897.642,180,849,648.917,579,873,914.43
经营活动现金流出小计5,113,114,503.773,470,847,821.681,840,752,541.56,968,860,743.32
经营活动产生的现金流量净额1,278,238,969.04832,040,075.96340,097,107.41611,013,171.11
投资活动产生的现金流量:
投资活动现金流入小计894,514,968.75794,200,757.18280,127,334.144,155,824,627.63
投资活动现金流出小计1,975,541,905.951,441,157,764.76478,507,141.732,543,790,861.8
投资活动产生的现金流量净额-1,081,026,937.2-646,957,007.58-198,379,807.591,612,033,765.83
筹资活动产生的现金流量:
筹资活动现金流入小计---1,182,500,000
筹资活动现金流出小计7,307,247.285,423,118.14293,7603,435,683,165.72
筹资活动产生的现金流量净额-7,307,247.28-5,423,118.14-293,760-2,253,183,165.72
汇率变动对现金及现金等价物的影响234,642.31143,861.5181,373.65105,273.7
现金及现金等价物净增加额190,139,426.87179,803,811.75141,504,913.47-30,030,955.08
期末现金及现金等价物余额1,006,742,601.27996,406,986.15958,108,087.87816,603,174.4
补充资料:
现金及现金等价物的净增加额-179,803,811.75--30,030,955.08
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华泰证券代雯,张云逸0.810.941.072025-10-28
TOP↑